Oral contraceptives, hormone therapy and cardiovascular risk.
about
Hormonal treatment of acne in women.Protective Hematopoietic Effect of Estrogens in a Mouse Model of Thrombosis: Respective Roles of Nuclear Versus Membrane Estrogen Receptor αOral contraceptive therapy increases oxidative stress in pre-menopausal women.Control of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2.Combined hormonal contraceptives: is it time to reassess their role in migraine?Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women.Oral versus vaginal combined hormonal contraceptives' effect on coagulation and inflammatory biomarkers among young adult women.
P2860
Q34074139-610D05A1-382C-4049-9851-895FA40F8418Q36164304-223F3545-94AD-4DC5-8D70-418606063F9FQ36489070-541EEE8A-5989-4B0B-89CA-515ADA1662D8Q36850156-A8F05740-070B-4EBD-9279-19E58484257FQ37973415-C4EF1FF7-98DB-4CB0-B099-17A2962BFFE9Q43133482-07324D2F-7B45-40F9-8D56-8196CA3187E6Q51352160-F0776024-6E4E-4CD6-9484-CDDDA0EB71B0
P2860
Oral contraceptives, hormone therapy and cardiovascular risk.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Oral contraceptives, hormone therapy and cardiovascular risk.
@en
Oral contraceptives, hormone therapy and cardiovascular risk.
@nl
type
label
Oral contraceptives, hormone therapy and cardiovascular risk.
@en
Oral contraceptives, hormone therapy and cardiovascular risk.
@nl
prefLabel
Oral contraceptives, hormone therapy and cardiovascular risk.
@en
Oral contraceptives, hormone therapy and cardiovascular risk.
@nl
P2860
P1433
P1476
Oral contraceptives, hormone therapy and cardiovascular risk.
@en
P2093
P2860
P304
P356
10.1080/13697130802322848
P577
2008-10-01T00:00:00Z